Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-08-001506
Filing Date
2008-02-29
Accepted
2008-02-28 21:58:13
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 KING PHARMACEUTICALS, INC. g11456e10vk.htm 10-K 2318098
2 EX-21.1 SUBSIDIARIES OF THE REGISTRANT g11456exv21w1.htm EX-21.1 3295
3 EX-23.1 CONSENT OF PRICEWATERHOUSECOOPERS LLP g11456exv23w1.htm EX-23.1 3435
4 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO g11456exv31w1.htm EX-31.1 9327
5 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO g11456exv31w2.htm EX-31.2 9319
6 EX-32.1 SECTION 906 CERTIFICATION OF THE CEO g11456exv32w1.htm EX-32.1 3902
7 EX-32.2 SECTION 906 CERTIFICATION OF THE CFO g11456exv32w2.htm EX-32.2 3894
8 GRAPHIC g11456g1145602.gif GRAPHIC 8697
  Complete submission text file 0000950144-08-001506.txt   2364770
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

EIN.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15875 | Film No.: 08652740
SIC: 2834 Pharmaceutical Preparations